Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H23NO |
| Molecular Weight | 245.3599 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
InChI
InChIKey=SWUVZKWCOBGPTH-UHFFFAOYSA-N
InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3
| Molecular Formula | C16H23NO |
| Molecular Weight | 245.3599 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Pyrovalerone is a psychostimulant. It has a central action. Pyrovalerone inhibits the dopamine transporter and the norepinephrine transporter, and is a weak inhibitor of the serotonin transporter. Pyrovalerone was demonstrated to reduce symptoms of chronic fatigue in humans. It stimulated locomotor activity in mice. Though pyrovalerone is still occasionally prescribed, it is used infrequently due to problems with abuse and dependence. Side effects of pyrovalerone include anxiety, fragmented sleep or insomnia and trembling, shaking or muscle tremors.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. | 2010-09 |
|
| Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure. | 2009-09-10 |
|
| A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone. | 2009-06-01 |
|
| 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. | 2006-02-23 |
|
| Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. | 2001-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:04 GMT 2025
by
admin
on
Mon Mar 31 18:23:04 GMT 2025
|
| Record UNII |
VOU69C02JP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Pyrovalerone
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
||
|
DEA NO. |
1485
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C005719
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
100000080852
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
PYROVALERONE
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
3563-49-3
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL201960
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
m9392
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
C83918
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
VOU69C02JP
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
1737
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
DTXSID20863194
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
14373
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
3511
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
SUB10177MIG
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |